Cardiovascular Surgery Devices and Equipment Global Market Report 2020-30: COVID-19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular surgery devices and equipment market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the cardiovascular surgery devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? the Cardiovascular Surgery Devices and Equipment Market Global Report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
Markets Covered:
1) by Product Type: Beating heart surgery systems; Cardiopulmonary Bypass Equipment; Cardiac Ablation Devices; Perfusion Disposables
2) by End User: Home and Ambulatory care; Hospitals; Diagnostic laboratories; Research laboratories
3) by Application: Congenital Heart Defects; Cardiac Arrhythmia; Coronary Heart Disease; Congestive Heart Failure; Other Applications
Companies Mentioned: Abbott Laboratories; Boston Scientific Corporation; Cook Medical; C.R.Bard; Abiomed
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:
Where is the largest and fastest growing market for the cardiovascular surgery devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? the Cardiovascular Surgery Devices and Equipment Market Global Report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The Market Characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Product Type: Beating heart surgery systems; Cardiopulmonary Bypass Equipment; Cardiac Ablation Devices; Perfusion Disposables
2) by End User: Home and Ambulatory care; Hospitals; Diagnostic laboratories; Research laboratories
3) by Application: Congenital Heart Defects; Cardiac Arrhythmia; Coronary Heart Disease; Congestive Heart Failure; Other Applications
Companies Mentioned: Abbott Laboratories; Boston Scientific Corporation; Cook Medical; C.R.Bard; Abiomed
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1. Executive Summary2. Cardiovascular Surgery Devices and Equipment Market Characteristics26. Key Mergers And Acquisitions In The Cardiovascular Surgery Devices and Equipment Market27. Cardiovascular Surgery Devices and Equipment Market Trends And Strategies28. Cardiovascular Surgery Devices and Equipment Market Future Outlook and Potential Analysis
3. Cardiovascular Surgery Devices and Equipment Market Size And Growth
4. Cardiovascular Surgery Devices and Equipment Market Segmentation
5. Cardiovascular Surgery Devices and Equipment Market Regional And Country Analysis
6. Asia-Pacific Cardiovascular Surgery Devices and Equipment Market
7. China Cardiovascular Surgery Devices and Equipment Market
8. India Cardiovascular Surgery Devices and Equipment Market
9. Japan Cardiovascular Surgery Devices and Equipment Market
10. Australia Cardiovascular Surgery Devices and Equipment Market
11. Indonesia Cardiovascular Surgery Devices and Equipment Market
12. South Korea Cardiovascular Surgery Devices and Equipment Market
13. Western Europe Cardiovascular Surgery Devices and Equipment Market
14. UK Cardiovascular Surgery Devices and Equipment Market
15. Germany Cardiovascular Surgery Devices and Equipment Market
16. France Cardiovascular Surgery Devices and Equipment Market
17. Eastern Europe Cardiovascular Surgery Devices and Equipment Market
18. Russia Cardiovascular Surgery Devices and Equipment Market
19. North America Cardiovascular Surgery Devices and Equipment Market
20. USA Cardiovascular Surgery Devices and Equipment Market
21. South America Cardiovascular Surgery Devices and Equipment Market
22. Brazil Cardiovascular Surgery Devices and Equipment Market
23. Middle East Cardiovascular Surgery Devices and Equipment Market
24. Africa Cardiovascular Surgery Devices and Equipment Market
25. Cardiovascular Surgery Devices and Equipment Market Competitive Landscape And Company Profiles
29. Appendix
Executive Summary
Major players in the cardiovascular surgery devices and equipment market are Abbott Laboratories, Boston Scientific Corporation, Cook Medical, C.R.Bard and Abiomed.The global cardiovascular surgery devices and equipment market is expected to decline from $19.1 billion in 2019 to $15.6 billion in 2020 at a compound annual growth rate (CAGR) of -18.5%. The decline is mainly because of the lockdown measures due to the COVID-19 outbreak. The decrease in the demand for cardiovascular devices due to decreased number of cardiac surgeries for reasons such as re-scheduling of surgeries, cancellations and no-show by patients, coupled with the restrictions by government and health authorities to shutdown factories manufacturing these devices to contain the spread of virus and keep the staff safe, contribute to this decline. The market is then expected to recover and grow at a CAGR of 5.9% from 2021 and reach $24.3 billion in 2023.
The cardiovascular surgery devices and equipment market consists of sales of cardiovascular surgery devices and related services. Cardiovascular surgery devices and equipment are used in cardiac surgery and other cardiovascular procedures performed to repair structural defects of the cardiovascular system of the heart and its damaged or blocked valves and vessels. Cardiovascular surgery devices are divided into perfusion disposables, beating heart surgery systems, cardiopulmonary bypass equipment and cardiac ablation devices.
North America was the largest region in the cardiovascular surgery devices and equipment market in 2018. This region is expected to remain the largest during the next five years. The cardiovascular surgery devices and equipment market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.
The U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) made public, its priority list for medical device guidance documents for the fiscal year 2017. This would allow the companies in promoting innovation and as well save them from the stringent consequences of non-approval of any product. Thus, a clearer and transparent approval method would drive the cardiovascular surgical devices market in the future.
The cardiovascular surgical devices market may be restrained due to stringent and longer approval process by the regulatory authorities. According to a researcher from Harvard Business School, innovative first-mover products such as implantable defibrillators or trans-catheter heart valves are delayed for approvals by FDA, thereby adding to the development cost to the manufacturer. For new cardiovascular devices (first-entrants), the innovator spends 7.2 months longer than the first follow-on innovator. For example, Edwards Lifesciences trans-catheter heart valve, was approved in Europe 4 years before it was approved in the USA. The study also estimated the financial loss associated with the delay in getting the approval. The delay may cost firms an average of $6.7 million to the already existing $94 million average price to introduce a new medical device to market, thereby hampering companies’ pursuit on new innovations.
Companies in the cardiovascular surgery devices and equipment market are investing in second generation bioresorbable stents and as well rectifying the glitches which occurred in the earlier version of bioresorbable stents. This advancing segment is poised to garner $247 million by 2025. Due to the all-new device features such as thinner strut thicknesses, faster resorption times, and better radial force, these are expected to grow at a higher growth rate. A higher elective procedure volume due to the less-invasive nature of PCIs when compared to coronary artery bypass grafting is expected to drive bioresorbable stents adoption. For instance, Amaranth Medical has developed three medical devices with thinner strut thickness, latest bearing a magnitude of 100 microns.
Rising geriatric population along with the rising deaths related to cardiovascular disorders is driving the cardiovascular surgical devices market. According to American Heart Association (AHA), in the US, approximately 43.7 million aged above 60 suffered from cardiovascular disorders. It is also reported by AHA that death related to cardiac diseases amount to 17.3 million per year and is expected to rise to more than 23.6 million by 2030, world-wide. Due to these factors, higher number of surgeries are being performed, thereby driving the market.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Boston Scientific Corporation
- Cook Medical
- C.R.Bard
- Abiomed
- St.Jude medical
- Angiodynamics Inc.
- Transmedics
- Terumo Cardiovascular Systems Corporation
- Edwards Life Science Corporation
- Medtronic Inc.
- Cook Medical
- Cardinal Health
- Cyberheart Incorporated
- Medwaves Incorporated
- Thoratec Corporation
- Cordis Corporation
- Getinge Group
- Atrion Corporation
- Sorin S.P.A.
- Terumo Medical Corporation
- Biosensors International
- Bioventrix Inc
- Maquet GmbH & Co. KG
- Sorin Group
- EndoPhotonix Inc.
- Krdium Inc.
- SEMMT Inc.
- Amaranth Medical
- Angiodynamics
Methodology
LOADING...